Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (8049) Stock Price & Analysis

2 Followers

8049 Stock Chart & Stats

HK$2.65HK$0.01(0.38%)
At close: 4:00 PM GMT+8
HK$2.2HK$2.4HK$2.6Aug 10Aug 25Sep 7Sep 21Oct 2Oct 21Nov 2
Day’s Range
HKD 2.63 - HKD 2.69
52-Week Range
HKD 1.82 - HKD 3.00
Previous Close
HKD 2.64
Volume
N/A
Average Volume (3M)
25.87K
Market Cap
HKD 1.48B
Enterprise Value
HKD 245.91M
Total Cash (Recent Filing)
HKD 902.41M
Total Debt (Recent Filing)
HKD 399.93K
Price to Earnings (P/E)
4.5
Beta
0.31
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jun 22, 2026
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Sustained Profitability

Consistently high gross and net margins indicate that the company has maintained solid economic performance across multiple years. Stable operating profitability supports internal funding, strengthens resilience during slower growth, and provides a durable base for continued pharmaceutical operations.

Conservative Balance Sheet

A conservative capital structure gives the company financial flexibility and reduces pressure from debt servicing. Growing equity provides a stronger base for absorbing business volatility, supporting operations, and funding future investment without excessive reliance on external financing.

Strong Cash Generation

Free cash flow that broadly tracks net income suggests earnings are being converted into usable cash rather than remaining primarily accounting-based. The strong 2025 level improves capacity to support operations, reinvest in the business, and maintain financial flexibility.

Bears Say

Cooling Revenue Growth

Recent top-line momentum has weakened after stronger expansion in 2021–2022, with revenue essentially flat in 2023, modestly higher in 2024, and slightly lower in 2025. Persistent softness could limit operating leverage and temper future earnings growth.

Volatile Cash Conversion

Although recent cash generation is strong, the history shows meaningful year-to-year variability in free cash flow. Uneven conversion can make internally generated funding less predictable and may complicate planning for investment, working capital needs, or shareholder returns.

Recent Debt Increase

The recent increase in debt introduces a less conservative element to an otherwise strong balance sheet. Even at manageable levels, higher borrowing can increase financing obligations and reduce flexibility if profitability or cash generation weakens over the next several periods.

8049 FAQ

What was Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price range in the past 12 months?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H lowest stock price was HK$1.82 and its highest was HK$3.00 in the past 12 months.
What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap is HK$1.48B.
When is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s earnings last quarter?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H released its earnings results on Aug 14, 2026. The company reported HK$0.25 earnings per share for the quarter.
Is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pay dividends?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pays a Notavailable dividend of HK$0.287 which represents an annual dividend yield of ―. See more information on Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H dividends here
What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H have?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 172,500,000 shares outstanding.
What happened to Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price movement after its last earnings report?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H reported an EPS of HK$0.25 in its last earnings report. Following the earnings report the stock price went down -3.664%.
Which hedge fund is a major shareholder of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:8049
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology